Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients
Authors:
- S. KushwahaSKS. Kushwaha
- B. HuntBHB. Hunt
- A. MackenAMA. Macken
- M. YacoubMYM. Yacoub
- G. ThompsonGTG. Thompson
- D. RobinsonDRD. Robinson
- Andrew MitchellAMAndrew Mitchell
- 1 December 1992
- journal article
- Published by Elsevier in The Lancet
- Vol. 340 (8834-8835) , 1500-1502
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Anti-endothelial antibodies and coronary artery disease after cardiac transplantationThe Lancet, 1992
- Lipoprotein(a)BMJ, 1991
- Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heartInternational Journal of Cardiology, 1991
- Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery diseaseThe American Journal of Cardiology, 1991
- Acute myocardial infarction in cardiac transplant recipientsThe American Journal of Cardiology, 1989
- Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infectionThe American Journal of Cardiology, 1989
- Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients.Circulation, 1988
- Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.Circulation, 1987
- Cardiac Transplantation: Where Are We?New England Journal of Medicine, 1986
- LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in cultureAtherosclerosis, 1979